Allied Market Research

2024

Gi Stool Testing Market

gi stool testing Market Size, Share, Competitive Landscape and Trend Analysis Report by Product Type (Reagents, Instruments), by Test (Ova and Parasites Test, Bacteria Test, Occult Blood Test, Stool Biomarkers Tests, Others) and by End User (Hospitals, Diagnostic Centres and Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

GI stool testing is the diagnosis of faeces or stool samples to analyse or detect digestive tract infections or diseases. GI disorders include diseases such as bowel inflammation, malabsorption, cancer, and others.

The growing prevalence of GI diseases due to the increasing consumption of junk food, stress & hectic lifestyle, and the rise of the geriatric population that is highly susceptible to GI infections drive the GI stool testing market growth. Furthermore, increasing healthcare awareness and increasing investments in the healthcare sector by the government and private sector is anticipated to fuel the market growth. However, significant levels of government rules & regulations associated with the GI stool testing and dearth of skilled personnel are the major barriers for the growth of the market. Ongoing R&D in the field of GI stool testing is anticipated to create new opportunities during the forecast period.

The market is segmented on the basis of tests, product type, end-user, and region. Based on tests, the market is categorized into microscopy test, ova & parasites test, culture test, bacteria test, occult blood test, stool biomarkers test, and others. Based on product type, the GI stool testing market is classified into reagents and instruments. By end-user, the market is divided into hospitals, diagnostic centres & laboratories, academic institutions, research centres & organizations, and home. By region, it has been analysed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global GI stool testing market, with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities in terms of value.
  • Extensive analysis of different segments helps understand various products of the market.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

gi stool testing Market Report Highlights

Aspects Details
gi stool testing Market By Product Type
By Product Type
  • Reagents
  • Instruments
gi stool testing Market By Test
By Test
  • Ova and Parasites Test
  • Bacteria Test
  • Occult Blood Test
  • Stool Biomarkers Tests
  • Others
gi stool testing Market By End User
By End User
  • Hospitals
  • Diagnostic Centres and Laboratories
  • Others
gi stool testing Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players
Key Market Players

Thermo Fisher Scientific, Cepheid, Luminex, R-Biopharm, Roche, Siemens Healthineers, Hologic, BD, QIAGEN, Meridian Bioscience

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

gi stool testing Market

Global Opportunity Analysis and Industry Forecast, 2023-2032